Mkts

Humacyte, Inc.

NASDAQ: HUMA
$0.55-0.01 (-2.20%)
As of Nov 16, 11:11 AM ET

Key statistics

Day range
0.540.58
52-week range
0.341.52
Today
Open0.55
Previous close0.55
Volume—
Valuation
Market cap155.12M
P/E ratio—
EPS (TTM)-0.49
Income & risk
Dividend / yield—
Beta2.86
Avg volume6.29M
Discussion

HUMA News

Stories mentioning HUMA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue495.00467.00753.00301.00517.000.000.000.00
Cost of Goods Sold2,0389,082260.00213.00147.000.000.000.00
Gross Profit(1,543)(8,615)493.0088.00370.000.000.000.00
Operating Expenses
Research & Development19,46214,60517,27322,00615,41820,65622,92623,753
Sales General & Admin7,6107,8098,1367,3075,746
Total Operating Expenses28,08830,23329,499
Operating Income (Loss)(28,935)(30,836)(24,390)(29,727)(23,184)(28,088)(30,233)(29,499)
Interest Income330.00503.00590.00832.00662.00852.00911.001,310
Interest Expense
Other Expense
Pretax Income
Tax Provision0.000.000.000.000.000.000.000.00
Net Income (Loss)(17,619)(24,804)(17,510)(37,658)39,139(20,940)(39,202)(56,663)
Earnings Per Share (Basic)(0.09)(0.16)(0.11)(0.24)0.28(0.18)(0.33)(0.48)
Earnings Per Share (Diluted)(0.09)(0.16)(0.11)(0.24)0.28(0.18)(0.33)(0.48)
Weighted Average Shares Outstanding (Basic)197,847158,160158,313155,437131,497118,479119,409119,175
Weighted Average Shares Outstanding (Diluted)197,847158,160158,313155,437131,759118,479119,409119,175

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About HUMA

Humacyte, Inc. (NASDAQ: HUMA) is a stock listed on the Nasdaq Stock Market under the ticker symbol HUMA. It last traded at $0.5500 (Nov 16, 2026, 11:11 AM ET), down 2.2% on the day. That gives Humacyte a market capitalisation of $155.1M.

Over the past 52 weeks HUMA has traded between $0.3400 and $1.52.

Revenue for the quarter ended Mar 31, 2026 was $495.0K; a net loss of $17.6M. Revenue was down 4.3% from $517.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$495.0K-$17.6M-3559.4%
Dec 31, 2025$467.0K-$24.8M-5311.3%
Sep 30, 2025$753.0K-$17.5M-2325.4%
Jun 30, 2025$301.0K-$37.7M-12511.0%

From Humacyte’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…